• X-Hero and Male Enhancer: Recall – Undeclared Drug Ingredient

    This is a reprint of the FDA alert. ISSUE: FDA lab analysis of X-Hero found the product contains sulfosildenafil, the analogue of the active ingredient of an FDA-approved drug used to treat erectile dysfunction (ED), making X-Hero an unapproved drug. In addition, FDA analysis of […]

  • 20 Tons of Fake Antibiotics, Analgesics and Other Medicines Collected in Peru

    Peruvian officials have confiscated 20 tons of fake medication since 2007. 30% of the fakes confiscated were counterfeit antibiotics and another 30% fraudulent analgesics. Peru’s General Agency for Medicine and Drugs (Digemid) reported that antibiotics, analgesics and anti-inflammatories are the most fake medications in Peru, […]

  • Drug Dealers Moving into Counterfeit Medications in US Suburbs

    In three separate suburban communities, people were arrested this week for possession of counterfeit drugs in the Washington, DC area and in Ohio suburbs. In Findlay, Ohio, Matthew Snodgrass, 23, faces charges of trafficking in drugs and counterfeit controlled substances, reports WFIN. Snodgrass is accused […]

  • Medicine Cargo Drivers Vanished with Cargo in Russia

    Two men, driving two separate cargo trucks of medication disappeared on March 13th in Russia, as did their trucks and the cargo within them, after crossing the Russian border from Finland. The two men, aged 60 and 25, disappeared on March 13. Subsequently, the two […]

  • PSM Board Members Speak at 7th Annual San Diego Health Policy Conference, “Public-Private Partnerships in Global Health”

    The reality that key issues in healthcare go beyond geo-
    political lines is evident by challenges associated with important public
    health concerns. Pandemics, human-sourced disasters, drug safety, HIV-
    AIDS and TB control and treatment all represent global circumstances
    that require a wide array of stakeholder efforts to effectively address.

    Simultaneously, a much broader range of global health organizations have
    increasingly played a role in addressing these and other international
    public health needs beyond traditional public health authorities.
    Foundations, international agencies outside the health realm, and the
    private sector have also become key participants in creating policies and
    programs in an effort to promote global public health.

    Hence, the Institute of Health Law Studies (IHLS) convened the 7th Annual
    San Diego Health Policy Conference
    , entitled “Public-Private Partnerships
    in Global Health.” The conference explored different models of public-
    private partnerships emerging from the expansion of global health activities
    to these larger bodies of groups, and will provide lessons for participants,
    providers, and policymakers as to how to best engage these entities and
    systems to most effectively and efficiently advance global health.

  • PSM Board Members Speak at 7th Annual San Diego Health Policy Conference, “Public-Private Partnerships in Global Health”

    The reality that key issues in healthcare go beyond geo-
    political lines is evident by challenges associated with important public
    health concerns. Pandemics, human-sourced disasters, drug safety, HIV-
    AIDS and TB control and treatment all represent global circumstances
    that require a wide array of stakeholder efforts to effectively address.

    Simultaneously, a much broader range of global health organizations have
    increasingly played a role in addressing these and other international
    public health needs beyond traditional public health authorities.
    Foundations, international agencies outside the health realm, and the
    private sector have also become key participants in creating policies and
    programs in an effort to promote global public health.

    Hence, the Institute of Health Law Studies (IHLS) convened the 7th Annual
    San Diego Health Policy Conference
    , entitled “Public-Private Partnerships
    in Global Health.” The conference explored different models of public-
    private partnerships emerging from the expansion of global health activities
    to these larger bodies of groups, and will provide lessons for participants,
    providers, and policymakers as to how to best engage these entities and
    systems to most effectively and efficiently advance global health.

  • PSM Board Members Speak at 7th Annual San Diego Health Policy Conference, “Public-Private Partnerships in Global Health”

    Tom Kubic speaking at another conferenceby Safe Medicines via Flickr. The reality that key issues in healthcare go beyond geo- political lines is evident by challenges associated with important public health concerns. Pandemics, human-sourced disasters, drug safety, HIV- AIDS and TB control and treatment all […]

  • Conference speakers, left to right: Scott LaGanga, Tom Kubic, Tom Novotny, Bryan Liang, Louise Gresham, Tim Mackey.

  • 15 South Korean Pharmacists Indicted for Selling Fake Drugs

    Investigators at the Seoul Central District Prosecutors Office have filed indictments against fifteen Seoul pharmacists for selling fake erectile dysfunction medications manufactured in China. Reports the Korea Herald, this is the first time pharmacists have been charged with selling fake medication in Seoul. Prosecutors say […]

  • South America and Africa Employ Anti-Counterfeiting Technologies to Save Lives

    Responding to the ongoing cases of counterfeiters in their countries, Argentinian and Nigerian pharmaceutical manufacturers are installing anti-counterfeiting solutions in their products. Gador Laboratories, located in Buenos Aires, is deploying a radio frequency identification (RFID) solution to track products and pallets, after a month-long pilot. […]

Page 1 of 512345